| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |